Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
285.3 USD | +1.84% | -2.55% | -11.65% |
Evolution of the average Target Price on Bio-Rad Laboratories, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Bio-Rad Laboratories, Inc.
Zacks Investment Research | |
RBC Capital Markets | |
Citigroup | |
UBS | |
Wells Fargo Securities | |
Credit Suisse | |
B. Riley |
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BIO Stock
- Consensus Bio-Rad Laboratories, Inc.